Citation: | Ouyang Qing, Tan Xiaoyu, Huo Feng. Attaching importance to mechanical perfusion of donor liver and promoting high-quality development of liver transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(1): 1-7. doi: 10.3969/j.issn.1674-7445.2021.01.001 |
[1] |
CZIGANY Z, TACKE F, LURJE G. Evolving trends in machine liver perfusion: comments on clinical end points and selection criteria[J]. Gastroenterology, 2019, 157(4):1166-1167. DOI: 10.1053/j.gastro.2019.02.051.
|
[2] |
WHITE SL. Nudging the organ discard problem[J]. Transplantation, 2017, 101(7):1518-1519. DOI: 10.1097/TP.0000000000001718.
|
[3] |
NAIR A, HASHIMOTO K. Extended criteria donors in liver transplantation-from marginality to mainstream[J]. Hepatobiliary Surg Nutr, 2018, 7(5):386-388. DOI: 10.21037/hbsn.2018.06.08.
|
[4] |
GANDOLFINI I, BUZIO C, ZANELLI P, et al. The kidney donor profile index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes[J]. Am J Transplant, 2014, 14(11):2515-2525. DOI: 10.1111/ajt.12928.
|
[5] |
FUDIM M, DAVIS ME, JENKINS C, et al. Marginal donor use in patients undergoing heart transplantation with left ventricular assist device explantation[J]. Ann Thorac Surg, 2015, 100(6):2117-2126. DOI: 10.1016/j.athoracsur.2015.05.110.
|
[6] |
ADAM R, KARAM V, CAILLIEZ V, et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation[J]. Transpl Int, 2018, 31(12):1293-1317. DOI: 10.1111/tri.13358.
|
[7] |
黄洁夫.中国器官移植发展报告(2015-2018)[R].昆明: 中国器官移植发展基金会, 2019.
|
[8] |
CZIGANY Z, LURJE I, TOLBA RH, et al. Machine perfusion for liver transplantation in the era of marginal organs-new kids on the block[J]. Liver Int, 2019, 39(2):228-249. DOI: 10.1111/liv.13946.
|
[9] |
HERRERO TORRES MA, DOMNIGUEZ BASTANTE M, MOLINA RAYA A, et al. Eight years of extracorporeal membrane oxygenation in liver transplantation: our experience[J]. Transplant Proc, 2020, 52(2):572-574. DOI: 10.1016/j.transproceed.2019.11.050.
|
[10] |
HAGNESS M, FOSS S, SøRENSEN DW, et al. Liver transplant after normothermic regional perfusion from controlled donors after circulatory death: the Norwegian experience[J]. Transplant Proc, 2019, 51(2):475-478. DOI: 10.1016/j.transproceed.2019.01.066.
|
[11] |
HESSHEIMER AJ, COLL E, TORRES F, et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation[J]. J Hepatol, 2019, 70(4):658-665. DOI: 10.1016/j.jhep.2018.12.013.
|
[12] |
CHO Y, KIM C, KANG B. Risk of bias assessment of randomised controlled trials referenced in the 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care: a cross-sectional review[J]. BMJ Open, 2019, 9(5):e023725. DOI: 10.1136/bmjopen-2018-023725.
|
[13] |
ZHANG Y, ZHANG Y, ZHANG M, et al. Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a Meta-analysis[J]. Medicine (Baltimore), 2019, 98(23):e16033. DOI: 10.1097/MD.0000000000016033.
|
[14] |
KRON P, SCHLEGEL A, MANCINA L, et al. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans[J]. J Hepatol, 2017, 68(1):82-91. DOI: 10.1016/j.jhep.2017.08.028.
|
[15] |
THORNE AM, UBBINK R, BRÜGGENWIRTH IMA, et al. Hyperthermia-induced changes in liver physiology and metabolism: a rationale for hyperthermic machine perfusion[J]. Am J Physiol Gastrointest Liver Physiol, 2020, 319(1):G43-G50. DOI: 10.1152/ajpgi.00101.2020.
|
[16] |
SCHLEGEL A, MULLER X, KALISVAART M, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation[J]. J Hepatol, 2019, 70(1):50-57. DOI: 10.1016/j.jhep.2018.10.005.
|
[17] |
MARTINS PN, BUCHWALD JE, MERGENTAL H, et al. The role of normothermic machine perfusion in liver transplantation[J]. Int J Surg, 2020, 82(Suppl):52-60. DOI: 10.1016/j.ijsu.2020.05.026.
|
[18] |
NASRALLA D, COUSSIOS CC, MERGENTAL H, et al. A randomized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557(7703):50-56. DOI: 10.1038/s41586-018-0047-9.
|
[19] |
ESHMUMINOV D, BECKER D, BAUTISTA BORREGO L, et al. An integrated perfusion machine preserves injured human livers for 1 week[J]. Nat Biotechnol, 2020, 38(2):189-198. DOI: 10.1038/s41587-019-0374-x.
|
[20] |
VON HORN C, BABA HA, HANNAERT P, et al. Controlled oxygenated rewarming up to normothermia for pretransplant reconditioning of liver grafts[J]. Clin Transplant, 2017, 31(11). DOI: 10.1111/ctr.13101.
|
[21] |
DE VRIES Y, MATTON APM, NIJSTEN MWN, et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution[J]. Am J Transplant, 2019, 19(4):1202-1211. DOI: 10.1111/ajt.15228.
|
[22] |
DENGU F, ABBAS SH, EBELING G, et al. Normothermic machine perfusion (NMP) of the liver as a platform for therapeutic interventions during ex-vivo liver preservation: a review[J]. J Clin Med, 2020, 9(4):1046. DOI: 10.3390/jcm9041046.
|
[23] |
FENG S, GOODRICH NP, BRAGG-GRESHAM JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index[J]. Am J Transplant, 2006, 6(4):783-790. DOI: 10.1111/j.1600-6143.2006.01242.x.
|
[24] |
WINTER A, FÉRAY C, AUDUREAU E, et al. A donor quality index for liver transplantation: development, internal and external validation[J]. Sci Rep, 2018, 8(1): 9871. DOI: 10.1038/s41598-018-27960-7.
|
[25] |
SCHLEGEL A, KALISVAART M, SCALERA I, et al. The UK DCD risk score: a new proposal to define futility in donation-after-circulatory-death liver transplantation[J]. J Hepatol, 2018, 68(3):456-464. DOI: 10.1016/j.jhep.2017.10.034.
|
[26] |
DE MEIJER VE, FUJIYOSHI M, PORTE RJ. Ex situ machine perfusion strategies in liver transplantation[J]. J Hepatol, 2019, 70(1):203-205. DOI: 10.1016/j.jhep. 2018.09.019.
|
[27] |
BHOGAL RH, MIRZA DF, AFFORD SC, et al. Biomarkers of liver injury during transplantation in an era of machine perfusion[J]. Int J Mol Sci, 2020, 21(5):1578. DOI: 10.3390/ijms21051578.
|
[28] |
MATTON APM, DE VRIES Y, BURLAGE LC, et al. Biliary bicarbonate, pH, and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers[J]. Transplantation, 2019, 103(7):1405-1413. DOI: 10.1097/TP.0000000000002500.
|
[29] |
WATSON CJE, KOSMOLIAPTSIS V, PLEY C, et al. Observations on the ex situ perfusion of livers for transplantation[J]. Am J Transplant, 2018, 18(8):2005-2020. DOI: 10.1111/ajt.14687.
|
[30] |
SCHREITER T, SOWA JP, SCHLATTJAN M, et al. Human ex-vivo liver model for acetaminophen-induced liver damage[J]. Sci Rep, 2016, 6:31916. DOI: 10.1038/srep31916.
|